Genprex, Inc. (GNPX)

↓ Download CSV

CIK 0001595248 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated TX
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-203.8%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$0$0$0$0$0$0$0$0
Operating Income-$15.52M-$21.17M-$31.06M-$23.83M-$20.67M-$17.96M-$10.68M-$12.36M-$3.31M-$4.13M
Net Income-$16.23M-$21.11M-$30.86M-$23.74M-$20.66M-$17.94M-$10.65M-$12.37M-$3.31M-$4.13M
EPS (Diluted)$-17.40$-266.89$-22.56$-19.80$-0.44
Total Assets$10.16M$4.12M$10.67M$25.09M$42.86M$31.37M$3.53M$9.27M$1.26M$1.91M
Total Liabilities$2.20M$2.50M$2.46M$1.59M
Shareholders' Equity$7.96M$1.62M$7.42M$22.27M$41.28M$30.92M$3.02M$8.88M$428.6K$1.62M
Cash & Equivalents$7.83M$1.60M$6.74M$20.95M$161.3K$1.60M
Operating Cash Flow-$15.31M-$17.92M-$24.74M-$17.62M-$14.28M-$13.94M-$6.92M-$6.85M-$2.17M-$1.25M
Capital Expenditures$0$31.7K$17.6K$33.4K$22.4K$5.9K$5.0K
Shares Outstanding3.29M217.2K1.49M1.20M47.87M43.12M19.26M15.24M11.72M11.36M